ATRC
Price
$23.17
Change
+$0.56 (+2.48%)
Updated
Apr 26, 6:59 PM EST
3 days until earnings call
TFX
Price
$206.67
Change
+$0.09 (+0.04%)
Updated
Apr 26, 6:59 PM EST
4 days until earnings call
Ad is loading...

Compare trend and price ATRC vs TFX

Header iconATRC vs TFX Comparison
Open Charts ATRC vs TFXBanner chart's image
AtriCure
Price$23.17
Change+$0.56 (+2.48%)
Volume$223.28K
CapitalizationN/A
Teleflex
Price$206.67
Change+$0.09 (+0.04%)
Volume$99.08K
CapitalizationN/A
View a ticker or compare two or three
ATRC vs TFX Comparison Chart

Loading...

ATRCDaily Signal changed days agoGain/Loss if shorted
 
Show more...
TFXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
ATRC vs. TFX commentary
Apr 28, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATRC is a Hold and TFX is a Hold.

COMPARISON
Comparison
Apr 28, 2024
Stock price -- (ATRC: $23.17 vs. TFX: $206.71)
Brand notoriety: ATRC and TFX are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: ATRC: 52% vs. TFX: 140%
Market capitalization -- ATRC: $1.45B vs. TFX: $10.49B
ATRC [@Medical Specialties] is valued at $1.45B. TFX’s [@Medical Specialties] market capitalization is $10.49B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $7.44B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATRC’s FA Score shows that 0 FA rating(s) are green whileTFX’s FA Score has 1 green FA rating(s).

  • ATRC’s FA Score: 0 green, 5 red.
  • TFX’s FA Score: 1 green, 4 red.
According to our system of comparison, TFX is a better buy in the long-term than ATRC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATRC’s TA Score shows that 4 TA indicator(s) are bullish while TFX’s TA Score has 2 bullish TA indicator(s).

  • ATRC’s TA Score: 4 bullish, 3 bearish.
  • TFX’s TA Score: 2 bullish, 5 bearish.
According to our system of comparison, ATRC is a better buy in the short-term than TFX.

Price Growth

ATRC (@Medical Specialties) experienced а -0.13% price change this week, while TFX (@Medical Specialties) price change was +0.07% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.43%. For the same industry, the average monthly price growth was -5.27%, and the average quarterly price growth was +16.21%.

Reported Earning Dates

ATRC is expected to report earnings on Jul 30, 2024.

TFX is expected to report earnings on Jul 25, 2024.

Industries' Descriptions

@Medical Specialties (+0.43% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
A.I.dvisor published
a Summary for ATRC with price predictions.
OPEN
A.I.dvisor published
a Summary for TFX with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
TFX($10.5B) has a higher market cap than ATRC($1.45B). ATRC has higher P/E ratio than TFX: ATRC (36.76) vs TFX (29.48). TFX YTD gains are higher at: -16.972 vs. ATRC (-35.080). TFX has higher annual earnings (EBITDA): 761M vs. ATRC (-8.11M). TFX has more cash in the bank: 223M vs. ATRC (137M). ATRC has less debt than TFX: ATRC (74.5M) vs TFX (1.93B). TFX has higher revenues than ATRC: TFX (2.97B) vs ATRC (399M).
ATRCTFXATRC / TFX
Capitalization1.45B10.5B14%
EBITDA-8.11M761M-1%
Gain YTD-35.080-16.972207%
P/E Ratio36.7629.48125%
Revenue399M2.97B13%
Total Cash137M223M61%
Total Debt74.5M1.93B4%
FUNDAMENTALS RATINGS
ATRC vs TFX: Fundamental Ratings
ATRC
TFX
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
67
Overvalued
18
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9276
PRICE GROWTH RATING
1..100
9062
P/E GROWTH RATING
1..100
9479
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TFX's Valuation (18) in the Medical Specialties industry is somewhat better than the same rating for ATRC (67). This means that TFX’s stock grew somewhat faster than ATRC’s over the last 12 months.

TFX's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as ATRC (100). This means that TFX’s stock grew similarly to ATRC’s over the last 12 months.

TFX's SMR Rating (76) in the Medical Specialties industry is in the same range as ATRC (92). This means that TFX’s stock grew similarly to ATRC’s over the last 12 months.

TFX's Price Growth Rating (62) in the Medical Specialties industry is in the same range as ATRC (90). This means that TFX’s stock grew similarly to ATRC’s over the last 12 months.

TFX's P/E Growth Rating (79) in the Medical Specialties industry is in the same range as ATRC (94). This means that TFX’s stock grew similarly to ATRC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ATRCTFX
RSI
ODDS (%)
Bullish Trend 3 days ago
68%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 3 days ago
68%
Momentum
ODDS (%)
N/A
Bearish Trend 3 days ago
65%
MACD
ODDS (%)
Bullish Trend 3 days ago
79%
Bearish Trend 3 days ago
67%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
78%
Bullish Trend 3 days ago
62%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
80%
Bearish Trend 3 days ago
68%
Advances
ODDS (%)
Bullish Trend 12 days ago
74%
Bullish Trend 5 days ago
64%
Declines
ODDS (%)
Bearish Trend 4 days ago
80%
Bearish Trend 10 days ago
67%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 3 days ago
66%
View a ticker or compare two or three
Ad is loading...
ATRCDaily Signal changed days agoGain/Loss if shorted
 
Show more...
TFXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IVNQX36.590.59
+1.64%
Invesco Nasdaq 100 Index R6
USAAX34.640.54
+1.58%
Victory Growth
EGFIX47.380.60
+1.28%
Edgewood Growth Instl
VVICX10.900.11
+1.02%
VOYA VACS Index Series SC Portfolio
CSUCX21.81-0.09
-0.41%
Cohen & Steers Global Infrastructure C

ATRC and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATRC has been loosely correlated with VCYT. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if ATRC jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATRC
1D Price
Change %
ATRC100%
+2.48%
VCYT - ATRC
49%
Loosely correlated
-0.87%
PEN - ATRC
46%
Loosely correlated
-0.53%
KIDS - ATRC
46%
Loosely correlated
+1.07%
TFX - ATRC
46%
Loosely correlated
N/A
MDT - ATRC
45%
Loosely correlated
+0.62%
More

TFX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TFX has been loosely correlated with MDT. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if TFX jumps, then MDT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TFX
1D Price
Change %
TFX100%
N/A
MDT - TFX
60%
Loosely correlated
+0.62%
ZBH - TFX
57%
Loosely correlated
-0.33%
BAX - TFX
55%
Loosely correlated
-0.25%
SNN - TFX
52%
Loosely correlated
+2.39%
ABT - TFX
49%
Loosely correlated
+0.63%
More